Open Tender Watch
Menu v
ACCESS EN PT
← Companies Company PT

GlaxoSmithKline Consumer Healthcare

NIF 500276994
↓ CSV ↓ JSON
Risk Flags
A1 · Repeat Direct Award €1,248,498 50 contracts
Same supplier receives ≥2 direct awards in 36 months with cumulative value above the CCP Art. 113 §2 statutory cap
HIGH €1,248,498 50 contracts
A2 · Late Publication €4,543,084,761 385 contracts
Contract published to BASE more than 10 days after the signing date
LOW €4,543,084,761 385 contracts
A5 · Threshold Splitting €1,067,170 17 contracts
Contract value falls within 5% below a procedural threshold (€5K / €20K / €75K / €150K / €5.35M). Score: 35 · Severity: Medium.
HIGH €1,067,170 17 contracts
A9 · Abnormal Price Reduction €6,119,820,902 179 contracts
Effective price exceeds base price by >50% (score 30) or >100% (score 55); or effective price is <50% of base (score 10, possible predatory bid or data error). Severity: Medium/High/Low.
LOW €6,119,820,902 179 contracts
B5 · Benford's Law Deviation €1,260,920,492 4 contracts
Entity's contract values deviate from the Benford leading-digit distribution (chi-square goodness-of-fit, min 20 contracts). Score: 35 (p<0.05) or 55 (p<0.01).
MEDIUM €1,260,920,492 4 contracts
C3 · Missing Mandatory Fields €282,015 7 contracts
CPV code, procedure type, or base price absent for the procedure type, or base price exceeds ±€1 trillion (implausible data entry). Score: 20 · Severity: Low.
LOW €282,015 7 contracts

Procurement Network

Aggregated links between this entity and connected counterparties

Public view excludes person-level links and tax identifiers.

Loading network…
Legend Focus entity Public body Company Anonymized individual

Contracts by Contracting Authority

3
€393,440,755
45
€334,937,180
9
€320,498,041
13
€316,845,291
19
€315,631,013
28
€315,621,426
5
€315,485,297
41
€315,484,314
19
€315,472,839
4
€315,377,781
19
€315,369,886
2
€315,351,004
4
€315,323,675
4
€315,258,794
2
€315,233,748
2
€315,232,223
5
€315,230,123
1
€315,230,123
1
€315,230,123
2
€7,922,034
Page 1 of 3 · 48 authorities
Next →

All Contracts Won

Signal: All A1 · Repeat Direct Award A2 · Late Publication A5 · Threshold Splitting A9 · Abnormal Price Reduction B5 · Benford's Law Deviation C3 · Missing Mandatory Fields

Page 1 of 1 · 17 contracts

040102162026 CLOROHEXIDINA, DIGLUCONATO 0.2 % COLUTÓRIO FR 300 ML
PT · 13073531 · Ajuste Direto Regime G...
A5 · Threshold Splitting
€4,788 2026-01-23
ADCM3064/25 - MEDICAMENTOS DIVERSOS
PT · 11616226 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication +1
€149,723 2025-07-11
VÁRIOS MEDICAMENTOS
PT · 11316574 · Ajuste Direto Regime G...
A5 · Threshold Splitting A1 · Repeat Direct Award
€19,154 2025-03-25
Aquisição de Medicamentos do Aparelho Digestivo 2
PT · 11251258 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€19,030 2025-01-15
41/4121/2024 Medicamentos Nicotina
PT · 10928357 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting
€4,772 2024-09-10
Convite à apresentação de propostas ao abrigo do(s) acordo(s)-quadro 2022/13 (Vacinas e tuberculinas) para aquisição da vacina contra a gripe
PT · 11184818 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting C3 · Missing Mandatory Fields
€143,451 2024-07-22
CLOROHEXIDINA, DIGLUCONATO 0.2 % COLUTÓRIO FR 300 ML
PT · 10888771 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication
€19,845 2024-07-12
Aquisição de Medicamentos do aparelho digestivo ao abrigo do Acordo Quadro 2022/14 para o ano 2024
PT · 10838895 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€146,907 2024-01-25
Medicamentos do Aparelho Digestivo AQ2022/14 - ano 2024
PT · 10510295 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€144,413 2024-01-01
Aquisição de Antissépticos, desinfetantes e produtos cosméticos para uso no humano ao abrigo do AQ 2022/8 para ano 2023
PT · 10100739 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€148,123 2023-02-16
221G001069 - CLOROHEXIDINA 0,2% SOL DENTAL FRS 300 ML - ANO 2022
PT · 9281030 · Ajuste Direto Regime G...
A5 · Threshold Splitting
€19,999 2022-05-26
Medicamentos do aparelho digestivo ao abrigo do CPA n.º 2019/014
PT · 9127089 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€71,637 2022-02-24
MEDICAMENTOS
PT · 5179636 · Ajuste Direto Regime G...
A5 · Threshold Splitting A1 · Repeat Direct Award +2
€4,819 2018-10-04
PA Nº 96/SF/HPSJD - Aquisição de bens para os Serviços Farmacêuticos do HPSJD para o ano de 2018
PT · 4993712 · Consulta Prévia
A5 · Threshold Splitting A2 · Late Publication +1
€71,898 2018-06-22
Aquisição de Medicamentos Exclusivos Glaxosmithkline II
PT · 4912776 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication
€19,634 2018-02-07
51000117 - MEDICAMENTOS C/CHNM
PT · 4072551 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication +1
€74,123 2017-01-16
CLEMASTINA - SOL INJ 1 mg / ml IM / IV - 2 ml
PT · 3501591 · Ajuste Direto Regime G...
A5 · Threshold Splitting A1 · Repeat Direct Award +2
€4,854 2015-09-28
Overview
Total Value Won
€6,124,057,481
Contracts Won
513
Score 20645 · CRITICAL RISK
NIF
500276994
Country
PT
Directors & Officers

Personal data is pseudonymised for public access. Authenticate with a journalist token to view full names and NIFs.

  • A.S. [P-d08c]
    Gerente
    since 2017-04-07
  • M.A. [P-3470]
    Gerente
    since 2011-11-21
  • M.R. [P-3a30]
    Gerente
    since 2020-09-17
  • N.J. [P-973d]
    Gerente
    since 2025-12-23
  • G.C. [P-31c7]
    Sócio
    since 2015-03-16
  • G.C. [P-31c7]
    Sócio
    since 2015-09-03
  • G.C. [P-fe91]
    Sócio
    since 2015-03-16
  • G.C. [P-fe91]
    Sócio
    since 2015-09-03
  • D.J. [P-3a3e]
    Gerente
    until 2009-06-04
  • J.P. [P-9310]
    Gerente
    until 2018-12-20
  • J.E. [P-db71]
    Gerente
    2008-06-16 → 2011-10-25
  • M.D. [P-0eaf]
    Gerente
    2009-03-13 → 2013-04-05
  • R.K. [P-e340]
    Gerente
    2018-12-20 → 2020-07-30
  • S.A. [P-c110]
    Gerente
    2013-04-05 → 2017-04-07
  • T.A. [P-a5a4]
    Gerente
    until 2015-01-28
Ownership & Registries

Beneficial ownership data (shareholders, directors, ultimate beneficial owners) is not yet imported. Links below open external public registries.

Registo Comercial (MJ) ↗ RCBE — Beneficial Ownership Register ↗

Full RCBE access requires judicial authentication (CJEU 2022 ruling limits public exposure).

Search in TED (EU procurement) ↗
Phase 7 — ownership layer planned